Learn More
Medchemexpress LLC Myristicin | 607-91-0 | 50 MG

Supplier: Medchemexpress LLC HYN251050MG
Myristicin is an orally bioavailable serotonin receptor antagonist and a weak monoamine oxidase (MAO) inhibitor. It is also the main component of nutmeg essential oil and demonstrates anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway.
- Possesses anti-cancer, anti-proliferative, antibacterial, anti-inflammatory, and apoptosis-inducing properties.
- Delays the proliferation of gastric cancer cells.
- Induces endoplasmic reticulum (ER) stress and apoptosis.
- Reduces cell cycle protein expression.
- Increases Bax expression.
- Activates caspase enzyme.
- Enhances cytochrome C release and mitochondrial ROS levels.
- Inhibits the growth of gastric cancer cells and the EGFR/ERK signaling pathway in animal models.
- Has preventive and protective effects against acetic acid-induced experimental colitis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.